Free Neurology CME

  • FREE

    Multiple Sclerosis in a Primary Care Setting: Employing Strategies for Appropriate Diagnosis and Improved Patient Outcomes

    Evidence shows that one of the major determinants of how well a patient with MS adheres to therapy is the relationship the patient has with his or her healthcare provider; the degree to which a patient feels support from his or her provider is actually an independent predictor of adherence, according to a survey of patients with self-reported progressive forms of MS.

    After completing Multiple Sclerosis in a Primary Care Setting: Employing Strategies for Appropriate Diagnosis and Improved Patient Outcomes physicians will better be able to:

    • Summarize the pathophysiology, symptomology, and clinical course of MS
    • Formulate strategies to encourage patients to discuss MS’ impact on their activities of daily living in a sensitive manner to identify problems that may be treated
    • Given a patient case, select appropriate treatment options for managing acute exacerbations of MS
    • Given a patient case, select appropriate treatment options for managing chronic symptoms associated with MS
    • Explain effective approaches to promoting patient adherence, managing adverse effects of therapy, and addressing other barriers to care

    Target Audience: Healthcare professionals specializing in: family medicine, geriatrics, internal medicine, primary care, or those who otherwise commonly care for patients with MS in the primary care setting.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: March 11, 2019
    • Expiration of CME credit: March 11, 2021
  • FREE

    A 360° Approach to Translating MS Data into Optimal Practice

    A 360° Approach to Translating MS Data into Optimal Practice focuses on practical topics, review clinical trial data with clarity and thoroughness, and incorporates cases to engage you on how this information can be used in clinical practice, for all disciplines involved in the care of patients with MS.

    Upon completion of A 360° Approach to Translating MS Data into Optimal Practice, you should be better able to:
    • Analyze data from clinical trials of disease modifying therapies to inform personalized treatment and monitoring of outcomes for patients with MS
    • Access reliable and evidence-based resources in order to stay current with advances in the management of MS
    • Integrate new and emerging information on the pathophysiology of MS, including modifiable risk factors, in the development of individualized treatment plans

    Target Audience:
    This educational initiative is intended to meet the needs of neurologists, nurses, nurse practitioners, physician assistants, rehabilitation professionals, case managers, mental health professionals, social workers and others involved in the management of patients with MS.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 3
    • CME credits awarded by: Consortium of Multiple Sclerosis Centers
    • Format: On-Demand Online, Online Audio
    • Material last updated: July 31, 2017
    • Expiration of CME credit: July 30, 2018
  • FREE

    Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy

    Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy emphasizes the use of IVIg in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy.

    The presentation consists of a single lecture, Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy, with discussion by Roy L. Freeman, MD, Richard J. Barohn, MD and Kenneth C. Gorson, MD.

    After viewing Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy, you will be better able to :
    • Conduct a thorough and timely evaluation and differential diagnosis of patients with chronic inflammatory demyelinating polyneuropathy.
    • Devise appropriate treatment regimen for the effective management of chronic inflammatory polyneuropathy based on guidelines and clinical evidence.

    Target Audiences:
    This program is intended for US-based neurologists, immunologists, physician assistants, nurse practitioners, and nurses who manage, or have an interest in managing patients with immune-mediated neuropathies.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: Postgraduate Institute for Medicine
    • Format: On-Demand Online, Online Video
    • Material last updated: July 27, 2017
    • Expiration of CME credit: July 27, 2018
  • FREE

    Neuropsychiatric Sequelae Virtual Curriculum Series: Agitation, Depression, and Pseudobulbar Affect

    Neuropsychiatric Sequelae Virtual Curriculum Series: Agitation, Depression, and Pseudobulbar Affect consists of two sections: Mechanisms and Management of Agitation in Alzheimer’s Disease and Challenges in Managing Treatment-Resistant Depression.

    After viewing Neuropsychiatric Sequelae Virtual Curriculum Series, you will be better able to:
    • Identify different and various forms of agitation among patients with Alzheimer’s disease (AD).
    • Review proposed mechanisms underlying agitation in AD and how pharmacologic agents may affect them
    • Evaluate body of evidence of current and emerging pharmacologic agents for the management of agitation/aggression in patients with AD

    Target Audiences:
    This program is intended for US-based neurologists, psychiatrists, geriatricians, primary care clinicians and health care providers involved in the care of patients with neuropsychiatric sequelae who may be suffering from agitation as a result of Alzheimer’s disease (AD).

    See full details chevron_right
    • Cost: Free
    • Credit hours: 2
    • CME credits awarded by: Albert Einstein College of Medicine
    • Format: On-Demand Online, Online Video
    • Material last updated: April 4, 2017
    • Expiration of CME credit: June 23, 2018
  • FREE

    Hereditary transthyretin amyloidosis (ATTR) treatment strategies: best practices and emerging therapies

    Transthyretin amyloidosis (ATTR) is a progressive, multisystem, life-threatening disorder characterized by the extracellular deposition of misfolded, insoluble amyloid fibrils.

    After completing Hereditary transthyretin amyloidosis (ATTR) treatment strategies: best practices and emerging therapies physicians will better be able to:

    • Describe the pathophysiology of ATTR such that it might inform treatment mechanisms
    • Describe available therapies used for treatment of ATTR and explain current literature supporting use of those therapies
    • Design and implement an appropriate therapeutic plan for treatment of ATTR
    • Describe future therapies currently being investigated for the treatment of ATTR

    Target Audience: neurologists, cardiologists, and hematologists; physician assistants, nurse practitioners, nurses, and pharmacists in the aforementioned areas of specialty; and any other HCPs with an interest in or who may clinically encounter patients with ATTR.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 0.75
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: March 28, 2019
    • Expiration of CME credit: March 28, 2021
  • FREE

    Updates in Alzheimer Disease (AD) and Its Complications: Pharmacotherapy and Barriers to Optimal Care

    This free online CME course provides key insights around Alzheimer’s Disease (AD) and will lead to better understanding and treatment of the condition.

    Topics covered in this course include:

    • AD Treatment
    • AD Patient Cases
    • AD Clinical Pearls
    • ADPathophysiological process
    • Epidemiology

    After completing this course, you will better be able to:

    • Describe validated diagnostic and screening method(s) for AD and apply them to a patient case
    • Discuss the neuropathophysiology of AD and how it relates to presently available AD treatments’ mechanisms
    • List present and emerging pharmacotherapeutic therapies for the treatment of AD and its complications and apply them to patient cases, taking into account comorbid disease states and drug therapies
    • Describe the impact of medication adherence on patient outcomes and formulate strategies to improve adherence in patients with AD

    Target audience: Healthcare professionals specializing in: neurology, gerontology, internal medicine, palliative care, or those who otherwise commonly care for patients with AD or who frequently encounter them or their caregivers in practice.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: July 07, 2018
    • Expiration of CME credit: July 07, 2020
  • FREE

    Parkinson’s Disease: Optimizing Pharmacotherapeutic Management Strategies

    This free online CME activity provides insights into Parkinson’s disease (PD) and will help improve treatment amongst patients suffering from the disease.

    Topics covered in this course include:

    • PD Epidemiology
    • PD Clinical features, presentation (motor symptoms), pathophysiology, risk factors (e.g., Gaucher’s disease, differential diagnosis and disease progression
    • PD Patient Cases
    • Treatment of PD

    After completing this course, you will better be able to:

    • Describe the epidemiology of PD and outline current and evolving diagnostic criteria
    • Describe the challenges associated with the diagnosis of PD
    • Identify the treatment modalities currently available for management of PD and its complications and apply them to patient cases using evidence-based medicine
    • List emerging pharmacologic therapies for the treatment of PD
    • Describe the impact of medication adherence on patient outcomes and formulate strategies to improve adherence in patients with PD

    Target Audience: Neurologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in neurology; and any other healthcare professionals with an interest in or who clinically encounter patients with PD.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1,25
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: March 27, 2018
    • Expiration of CME credit: March 27, 2020
  • FREE

    CME: Advanced prostate cancer: optimizing management strategies

    Prostate cancer is the most common form of malignancy among men in the United States.There are over 164,600 new cases and over 29,000 deaths from PC in the U.S. annually. Probable risk factors include age 65 and older, African American ancestry, family history, and mutations in the BRCA1, -2, MSH2, and HOXB13 genes, with possible risk factors including occupational exposure to cadmium, dietary factors, and higher concentrations of serum testosterone. About 95% of cases are adenocarcinoma, with neuroendocrine tumors, sarcomas, and transitional cell carcinomas comprising the balance of tumor types. Symptoms of advanced prostate cancer (aPC) include back pain, cord compression, lower extremity edema, pathologic fractures, anemia, and weight loss.

    By the end of the session the participant will be able to:

    • Recall the pathophysiology of aPC in a manner that informs treatment mechanisms
    • Describe differences in approach between hormone-sensitive and castration-resistant aPC
    • Identify the treatment modalities currently available for management of aPC and apply them to patient cases using evidence-based medicine
    • Describe emerging treatment options presently available for aPC, their mechanisms of action and safety, and anticipated place in therapy
    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 3/13/2020
    • Expiration of CME credit: 3/13/2021
  • FREE

    CME: Updates in the management of insomnia: therapeutic updates and optimizing treatment

    Insomnia is defined by the dissatisfaction of sleep quality or quantity characterized by having difficulty falling asleep, staying asleep, waking too early, or a combination of these. It is defined as chronic if the condition persists for three months, despite the opportunity for sleep or eradication of external stimulus. Insomnia affects people of all ages, though the likelihood of developing insomnia increases with age: reporting one-third of the adult population having been affected by at least one symptom of insomnia.

    By the end of the session the participant will be able to:

    • Describe the pathophysiology of insomnia such that it might inform treatment mechanisms
    • Identify the currently available and emerging pharmacotherapeutic treatments for management of insomnia and apply them to patient cases using evidence-based medicine
    • Evaluate a treatment plan for a specific patient with insomnia to optimize safety and efficacy, suggesting modifications for improvement
    • Describe barriers to care associated with treating patients with insomnia

    Target Audience: The following HCPs: neurologists, psychiatrists, sleep medicine specialists, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in the aforementioned areas of specialty; and those who otherwise have an interest in or commonly care for or clinically encounter patients with insomnia.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 10/18/2019
    • Expiration of CME credit: 10/18/2021